EP.09 - David Dexter, Associate Research Director of Parkinson's UK and Professor of Neuropharmacology at the Imperial College London
Powered by patients and their relatives, Parkinson's UK is the the largest charitable funder of Parkinson’s research in Europe. I had the chance to interview Associate Research Director David Dexter, also Professor of Neuropharmacology at the Imperial College London, about the latest developments in cell therapy for Parkinson's disease.
WATCH OUR LATEST TEASERS !
The story Behind
In the Stem Cell Jungle
The idea of having laid-back conversations with academic and industry leaders in the field of stem cells and cell therapy comes from Maxime Feyeux, co-founder and Chief Scientific Officer of TreeFrog Therapeutics.
Maxime was one the first PhD students to work on iPSCs in France, and authored an early paper on the genome instability of human pluripotent stem cells (Nature Biotech, 2008). With the webcast In the Stem Cell Jungle, he aims to share its passion for stem cells and their applications.